These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5060107)

  • 1. Inhibitory effect of diphenylhydantoin on the diabetogenic action of alloxan in the mouse.
    Mennear JH; Gossel TA
    Diabetes; 1972 Feb; 21(2):80-3. PubMed ID: 5060107
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the protective effect of diphenylhydantoin against alloxan diabetes in mice.
    Esposito-Avella M; Mennear JH
    Proc Soc Exp Biol Med; 1973 Jan; 142(1):82-5. PubMed ID: 4683268
    [No Abstract]   [Full Text] [Related]  

  • 3. [Plasma and pancreatic levels of diphenylhydantoin and their relation to protection from chemical diabetes induced alloxan in mice].
    Espósito Avella M; Martínez M; Vergara G
    Rev Med Panama; 1981 Sep; 6(3):278-88. PubMed ID: 7036239
    [No Abstract]   [Full Text] [Related]  

  • 4. [Inhibition of diabetogenic effect of alloxan by intraperitoneal administration of glucose in mice].
    Ratsimamanga AR; Chirvan-Nia P; Bibal-Prot P
    C R Acad Hebd Seances Acad Sci D; 1970 Aug; 271(6):599-602. PubMed ID: 4989914
    [No Abstract]   [Full Text] [Related]  

  • 5. [Morphological and biochemical studies of the effect of barbituric acid, ureidosuccinic acid, orotic acid, uracil and thymine on the diabetogenic effect of alloxan].
    Schmidt R; Methfessel J; Schultka R; Apel D
    Z Zellforsch Mikrosk Anat; 1968; 84(1):9-23. PubMed ID: 4881123
    [No Abstract]   [Full Text] [Related]  

  • 6. Production and study of experimental diabetes in mice with alloxan.
    Bhaveja UK; Aurora AL; Agarwal DS
    Indian J Pathol Microbiol; 1982 Jan; 25(1):1-5. PubMed ID: 7106904
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduction in the diabetogenic effect of alloxan in mice by treatment with the antineoplastic agent ICRF-187.
    El-Hage AN; Herman EH; Ferrans VJ
    Res Commun Chem Pathol Pharmacol; 1981 Sep; 33(3):509-23. PubMed ID: 7036302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Protective effect of diphenylhydantoin on the diabetogenic action of alloxan].
    Sneer A; Colev V; Dughir E; Sneer I
    Rev Med Chir Soc Med Nat Iasi; 1979; 83(1):87-91. PubMed ID: 545588
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of alloxan-induced diabetes by ethanol administration.
    Heikkila RE; Barden H; Cohen G
    J Pharmacol Exp Ther; 1974 Sep; 190(3):501-6. PubMed ID: 4415193
    [No Abstract]   [Full Text] [Related]  

  • 10. Diabetogenic action of alloxan following temporary interruption of arterial blood flow to pancreas in rats.
    Bilic N; Felber JP
    Diabetes; 1970 Feb; 19(2):81-4. PubMed ID: 4905638
    [No Abstract]   [Full Text] [Related]  

  • 11. Differences in the blood glucose response of mice to alloxan and alloxan-inhibiting compounds.
    Boquist L
    Acta Endocrinol (Copenh); 1979 Dec; 92(4):687-93. PubMed ID: 532524
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of prostaglandins against alloxan-induced diabetes mellitus.
    Sailaja Devi MM; Das UN
    Prostaglandins Leukot Essent Fatty Acids; 2006 Jan; 74(1):39-60. PubMed ID: 16297610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intraperitoneal needling on pancreatic beta-cell cytotoxicity mediated via alloxan in mice with an FVB/N genetic background.
    Amao H; Iwamoto R; Komukai Y; Dobashi Y; Takahashi K; Tohei A; Nakama K; Toyama-Honda K
    Exp Anim; 2009 Apr; 58(2):151-8. PubMed ID: 19448338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of gamma-hydroxybutyrate on alloxan induced diabetes in mice.
    Pierrefiche G; Topall G; Henriet I; Laborit H
    Res Commun Chem Pathol Pharmacol; 1991 Mar; 71(3):309-19. PubMed ID: 2047574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetogenic action of alloxan in short-term termination of the blood supply to the pancreas and spleen].
    Ul'ianov AM; Tarasov IuA
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1984; (8):48-51. PubMed ID: 6487685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of blood glucose in the dimethylthiourea-induced protection against alloxan-induced diabetes.
    Masukawa T; Nakanishi K
    Jpn J Pharmacol; 1994 Sep; 66(1):159-61. PubMed ID: 7861663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against alloxan inhibition of insulin release by glucose, cytochalasin B and diphenylhydantoin.
    Ishibashi F; Hamasaki A; Shibata Y; Natioh Y; Kawate R
    Hiroshima J Med Sci; 1976 Dec; 25(4):199-202. PubMed ID: 1027747
    [No Abstract]   [Full Text] [Related]  

  • 18. [Animal sensitivity to the diabetogenic action of alloxan during cold adaptation].
    Shorin IuP; Seliatitskaia VG; Nepomniashchikh GI; Pal'chikova NA; Khodova RR
    Biull Eksp Biol Med; 1984 Aug; 98(8):240-2. PubMed ID: 6466864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against alloxan-induced diabetes by diethyldithiocarbamate and disulfiram in mice.
    Masukawa T; Nakanishi K
    Jpn J Pharmacol; 1994 Mar; 64(3):141-6. PubMed ID: 8022115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevention of alloxan-induced diabetes by amygdalin.
    Heikkila RE; Cabbat FS
    Life Sci; 1980 Aug; 27(8):659-62. PubMed ID: 7412494
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.